TapewireFind a company

person · Reporting owner

Patterson Chad

Disclosed activity across 2 companies

Tapewire entity
24632
SEC CIK
0001850152

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
DEXCOM INCDXCM · Entity 3114EVP Global MarketingMay 09, 2022May 10, 2022
iRhythm Holdings, Inc.IRTC · Entity 1499CHIEF COMM & PRODUCT OFFICERAugust 07, 2026August 11, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

DEXCOM INC

Report date May 09, 2022 · Filed May 10, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect13,675 Reported balance After 2022-05-09 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2022-05-09 · Sale · Disposed 777 · Balance 13,675

F1: On June 14, 2021, Mr. Patterson adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Patterson. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023.

Filing footnotes · ownership attribution and instrument terms

F1: On June 14, 2021, Mr. Patterson adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Patterson. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023.

iRhythm Holdings, Inc.

Report date August 07, 2026 · Filed August 11, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect62,125 Ending reported balance After 2026-08-10 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2026-08-07 · Grant · Acquired 13,589 · Balance 69,218

F1: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 7, 2023.

Row 2 · 2026-08-10 · Sale · Disposed 7,093 · Balance 62,125

F2: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 7, 2023.

F2: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 10, 2026 Filed Aug 11, 2026 20:01 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 SaleCommon Stock 7,093 $124.65 $884,170.11
Disclosure

SEC source: 0001850152-26-000012 · wk-form4_1786478507.xml · nonDerivative · entry 2

Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,125

F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs.

Read SEC document
August 07, 2026 Filed Aug 11, 2026 20:01 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 GrantCommon Stock 13,589 $0.00 $0.00
Disclosure

SEC source: 0001850152-26-000012 · wk-form4_1786478507.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,218

F1 · shares: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 7, 2023.

Read SEC document
August 03, 2026 Filed Aug 4, 2026 20:01 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 SaleCommon Stock 2,712 $122.12 $331,191.88
Disclosure

SEC source: 0001850152-26-000010 · wk-form4_1785873670.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,629

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

Read SEC document
May 29, 2026 Filed Jun 1, 2026 20:34 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 GrantCommon Stock 177 $96.82 $17,136.26
Disclosure

SEC source: 0001850152-26-000008 · wk-form4_1780346050.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,341

F1 · shares: Mr. Patterson is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2025 through May 31, 2026. This transaction is exempt from Section 16(b) under Rule 16b-3.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 23:37 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 SaleCommon Stock 3,030 $128.44 $389,188.05
Disclosure

SEC source: 0001850152-26-000006 · wk-form4_1772581019.xml · nonDerivative · entry 2

Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,164

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

Read SEC document
March 02, 2026 Filed Mar 3, 2026 23:37 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 SaleCommon Stock 1,414 $128.44 $181,616.14
Disclosure

SEC source: 0001850152-26-000006 · wk-form4_1772581019.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,194

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

Read SEC document
February 25, 2026 Filed Feb 26, 2026 22:38 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 SaleCommon Stock 8,967 $135.42 $1,214,301.28
Disclosure

SEC source: 0001850152-26-000002 · wk-form4_1772145504.xml · nonDerivative · entry 2

Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,738

F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:41 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 GrantCommon Stock 10,870 $0.00 $0.00
Disclosure

SEC source: 0001850152-26-000004 · wk-form4_1772228463.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,608

F1 · shares: These securities are Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2027 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 22:38 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 GrantCommon Stock 17,318 $0.00 $0.00
Disclosure

SEC source: 0001850152-26-000002 · wk-form4_1772145504.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,705

F1 · shares: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on February 27, 2023.

Read SEC document
December 02, 2025 Filed Dec 3, 2025 21:35 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 SaleCommon Stock 280 $184.83 $51,752.40
Disclosure

SEC source: 0001850152-25-000007 · wk-form4_1764797755.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,387

F1 · shares: This transaction represents the sale of common stock originally acquired by the reporting person pursuant to the Issuer's Employee Stock Purchase Plan effected through a 10b5-1 plan.

Read SEC document
August 06, 2025 Filed Aug 7, 2025 20:57 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 SaleCommon Stock 2,555 $158.97 $406,168.35
Disclosure

SEC source: 0001850152-25-000005 · wk-form4_1754600252.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,667

F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 25, 2024.

Read SEC document
August 04, 2025 Filed Aug 5, 2025 21:02 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 SaleCommon Stock 2,707 $164.36 $444,921.71
Disclosure

SEC source: 0001388658-25-000199 · wk-form4_1754427734.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,222

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of RSUs.

Read SEC document
June 23, 2025 Filed Jun 24, 2025 20:15 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 SaleCommon Stock 936 $150.00 $140,400.00
Disclosure

SEC source: 0001388658-25-000162 · wk-form4_1750796127.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,929

F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 25, 2024.

Read SEC document
June 10, 2025 Filed Jun 11, 2025 20:21 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 SaleCommon Stock 363 $150.00 $54,450.00
Disclosure

SEC source: 0001388658-25-000158 · wk-form4_1749673286.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 49,865

F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 25, 2024.

Read SEC document
May 30, 2025 Filed Jun 3, 2025 20:16 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 GrantCommon Stock 298 $71.46 $21,295.08
Disclosure

SEC source: 0001388658-25-000154 · wk-form4_1748981789.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,228

F1 · shares: Mr. Patterson is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2024 through May 31, 2025. This transaction is exempt from Section 16(b) under Rule 16b-3.

Read SEC document
May 02, 2025 Filed May 5, 2025 20:10 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 SaleCommon Stock 1,300 $125.00 $162,500.00
Disclosure

SEC source: 0001388658-25-000109 · wk-form4_1746475828.xml · nonDerivative · entry 2

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,930

F1 · shares: Shares sold pursuant to a 10b5-1 trading plan.

Read SEC document
May 02, 2025 Filed May 5, 2025 20:10 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 SaleCommon Stock 7,210 $119.75 $863,397.50
Disclosure

SEC source: 0001388658-25-000109 · wk-form4_1746475828.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,230

F1 · shares: Shares sold pursuant to a 10b5-1 trading plan.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 21:03 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 SaleCommon Stock 2,756 $108.77 $299,770.12
Disclosure

SEC source: 0001388658-25-000064 · wk-form4_1741122207.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,440

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units.

Read SEC document
February 26, 2025 Filed Feb 27, 2025 21:08 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 SaleCommon Stock 13,229 $112.13 $1,483,367.77
Disclosure

SEC source: 0001388658-25-000052 · wk-form4_1740690527.xml · nonDerivative · entry 5

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,196

F5 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs.

Read SEC document
February 26, 2025 Filed Feb 27, 2025 21:08 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 GrantCommon Stock 12,118 $0.00 $0.00
Disclosure

SEC source: 0001388658-25-000052 · wk-form4_1740690527.xml · nonDerivative · entry 4

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,425

F4 · shares: These securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2026 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:08 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 GrantCommon Stock 25,546 $0.00 $0.00
Disclosure

SEC source: 0001388658-25-000052 · wk-form4_1740690527.xml · nonDerivative · entry 3

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,307

F3 · shares: Represents the acquisition of shares upon the determination of the Compensation Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on July 25, 2022.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:08 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 SaleCommon Stock 461 $118.98 $54,849.78
Disclosure

SEC source: 0001388658-25-000052 · wk-form4_1740690527.xml · nonDerivative · entry 2

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,761

F2 · shares: This transaction represents the sale of common stock originally acquired by the reporting person pursuant to the Issuer's Employee Stock Purchase Plan effected through a 10b5-1 plan.

Read SEC document
August 02, 2024 Filed Aug 5, 2024 21:35 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 SaleCommon Stock 3,012 $74.66 $224,875.92
Disclosure

SEC source: 0001388658-24-000147 · wk-form4_1722893711.xml · nonDerivative · entry 2

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,133

F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units.

Read SEC document
May 31, 2024 Filed Aug 5, 2024 21:35 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 PurchaseCommon Stock 280 $74.98 $20,994.40
Disclosure

SEC source: 0001388658-24-000147 · wk-form4_1722893711.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,145

F1 · shares: Includes 280 shares acquired under the Issuer's employee stock purchase plan on May 31, 2024 in transactions that were exempt under Rules 16b-3(c) and 16b-3(d).

Read SEC document
March 04, 2024 Filed Mar 5, 2024 21:52 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 SaleCommon Stock 1,077 $111.14 $119,697.78
Disclosure

SEC source: 0001388658-24-000060 · wk-form4_1709675527.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,865

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units.

Read SEC document
February 28, 2024 Filed Mar 2, 2024 00:19 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 GrantCommon Stock 10,742 $0.00 $0.00
Disclosure

SEC source: 0001388658-24-000045 · wk-form4_1709338758.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,942

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on February 28, 2025 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Read SEC document
November 30, 2023 Filed Feb 27, 2025 21:08 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 OtherCommon Stock 89 $72.49 $6,451.61
Disclosure

SEC source: 0001388658-25-000052 · wk-form4_1740690527.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,222

F1 · shares: Mr. Patterson is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2022 through November 30, 2023. This transaction is exempt from Section 16(b) under Rule 16b-3.

Read SEC document
August 02, 2023 Filed Aug 2, 2023 22:46 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 SaleCommon Stock 1,896 $100.49 $190,529.04
Disclosure

SEC source: 0001388658-23-000097 · wk-form4_1691016361.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,200

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of RSUs.

F2 · balance_after: Includes 372 shares acquired under the Issuer's employee stock purchase plan on May 31, 2023

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:22 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 GrantCommon Stock 10,674 $0.00 $0.00
Disclosure

SEC source: 0001388658-23-000024 · wf-form4_167771293772216.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,724

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2024 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Read SEC document
July 25, 2022 Filed Jul 27, 2022 20:16 UTC iRhythm Holdings, Inc. IRTC · Entity 1499 GrantCommon Stock 20,789 $0.00 $0.00
Disclosure

SEC source: 0001388658-22-000117 · wf-form4_165895297176854.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,789

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on August 1, 2023 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Read SEC document
July 25, 2022 Filed Nov 21, 2022 16:01 UTC Amendment iRhythm Holdings, Inc. IRTC · Entity 1499 GrantCommon Stock 21,050 $0.00 $0.00
Disclosure

SEC source: 0001388658-22-000161 · wf-form4a_166904644984279.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,050

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on August 1, 2023 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

F2 · acquired: The acquisition of 261 shares was omitted from the Reporting Person's original Form 4, filed July 27, 2022.

Read SEC document
May 09, 2022 Filed May 10, 2022 20:11 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 777 $342.77 $266,332.29
Disclosure

SEC source: 0001093557-22-000102 · edgardoc.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · EVP Global Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,675

F1 · shares: On June 14, 2021, Mr. Patterson adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Patterson. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023.

Read SEC document
April 11, 2022 Filed Apr 13, 2022 20:43 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 776 $498.75 $387,030.00
Disclosure

SEC source: 0001093557-22-000088 · edgardoc.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · EVP, Global Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,452

F1 · shares: On June 14, 2021, Mr. Patterson adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Patterson. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023.

Read SEC document
March 10, 2022 Filed Mar 14, 2022 20:22 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 776 $401.27 $311,385.52
Disclosure

SEC source: 0001093557-22-000061 · edgardoc.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · EVP, Global Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,228

F1 · shares: On June 14, 2021, Mr. Patterson adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Patterson. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023.

Read SEC document
March 09, 2022 Filed Mar 11, 2022 00:27 UTC DEXCOM INC DXCM · Entity 3114 Disposition to issuerCommon Stock 974 $406.06 $395,499.23
Disclosure

SEC source: 0001093557-22-000051 · edgardoc.xml · nonDerivative · entry 5

Patterson Chad · CIK 0001850152 · EVP, Global Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,004

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023.

Read SEC document
March 09, 2022 Filed Mar 11, 2022 00:27 UTC DEXCOM INC DXCM · Entity 3114 Disposition to issuerCommon Stock 223 $406.06 $90,550.64
Disclosure

SEC source: 0001093557-22-000051 · edgardoc.xml · nonDerivative · entry 4

Patterson Chad · CIK 0001850152 · EVP, Global Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,978

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023.

Read SEC document
March 09, 2022 Filed Mar 11, 2022 00:27 UTC DEXCOM INC DXCM · Entity 3114 Disposition to issuerCommon Stock 432 $406.06 $175,416.49
Disclosure

SEC source: 0001093557-22-000051 · edgardoc.xml · nonDerivative · entry 3

Patterson Chad · CIK 0001850152 · EVP, Global Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,201

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023.

Read SEC document
March 09, 2022 Filed Mar 11, 2022 00:27 UTC DEXCOM INC DXCM · Entity 3114 Disposition to issuerCommon Stock 192 $406.06 $77,962.89
Disclosure

SEC source: 0001093557-22-000051 · edgardoc.xml · nonDerivative · entry 2

Patterson Chad · CIK 0001850152 · EVP, Global Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,633

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023.

Read SEC document
March 08, 2022 Filed Mar 11, 2022 00:27 UTC DEXCOM INC DXCM · Entity 3114 GrantCommon Stock 5,297 $0.00 $5.30
Disclosure

SEC source: 0001093557-22-000051 · edgardoc.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · EVP, Global Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,825

F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

F2 · balance_after: Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 21:42 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 46 $413.97 $19,042.62
Disclosure

SEC source: 0001093557-22-000023 · edgardoc.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · EVP, Global Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,528

F1 · shares: On June 14, 2021, Mr. Patterson adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Patterson. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 12,528 unvested restricted stock units, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,394 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 575 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
December 15, 2021 Filed Dec 17, 2021 21:40 UTC DEXCOM INC DXCM · Entity 3114 GrantCommon Stock 2,925 $0.00 $2.93
Disclosure

SEC source: 0001093557-21-000288 · edgardoc.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · EVP, Global Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,528

F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/2 shall vest 24 months from the Grant Date, 1/8 shall vest 27 months from the Grant Date, 1/8 shall vest 30 months from the grant date, 1/8 shall vest 33 months from the Grant Date, and the remaining balance shall vest 36 months from the Grant Date. Share units represent a contingent right to receive one share of DexCom Inc. Common Stock.

F2 · balance_after: Included in this number are 12,528 unvested restricted stock units, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,394 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 575 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 23:13 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 141 $545.54 $76,921.14
Disclosure

SEC source: 0001093557-21-000237 · edgardoc.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · EVP, Global Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,603

F1 · shares: On June 14, 2021, Mr. Patterson adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Patterson. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 9,603 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,394 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 575 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 13, 2021 Filed Sep 15, 2021 20:14 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 156 $541.47 $84,469.32
Disclosure

SEC source: 0001093557-21-000229 · edgardoc.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · EVP, Global Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,744

F1 · shares: On June 14, 2021, Mr. Patterson adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Patterson. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 9,603 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,394 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 575 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 14, 2021 00:00 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 4 $542.02 $2,168.09
Disclosure

SEC source: 0001093557-21-000217 · edgardoc.xml · nonDerivative · entry 2

Patterson Chad · CIK 0001850152 · EVP, Global Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,900

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Included in this number are 9,603 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,394 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 575 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 14, 2021 00:00 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 287 $541.36 $155,370.32
Disclosure

SEC source: 0001093557-21-000217 · edgardoc.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · EVP, Global Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,904

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Included in this number are 9,603 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,394 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 575 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.